Marco Colombi
1Patents
1h-index
3Co-inventors
25Inventor score
Filing activity: Jan 9, 2012 → Jan 9, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8993587B2 | Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.